Optimization of light sources for prostate photodynamic therapy
- PMID: 26136612
- PMCID: PMC4484893
- DOI: 10.1117/12.590343
Optimization of light sources for prostate photodynamic therapy
Abstract
To deliver uniform photodynamic dose to the prostate gland, it is necessary to develop algorithms that optimize the location and strength (emitted power × illumination time) of each light source. Since tissue optical properties may change with time, rapid (almost real-time) optimization is desirable. We use the Cimmino algorithm because it is fast, linear, and always converges reliably. A phase I motexafin lutetium (MLu)-mediated photodynamic therapy (PDT) protocol is on-going at the University of Pennsylvania. The standard plan for the protocol uses equal source strength and equal spaced loading (1-cm). PDT for the prostate is performed with cylindrical diffusing fibers (CDF) of various lengths inserted to longitudinal coverage within the matrix of parallel catheters perpendicular to a base plate. We developed several search procedures to aid the user in choosing the positions, lengths, and intensities of the CDFs. The Cimmino algorithm is used in these procedures to optimize the strengths of the light catheters at each step of the iterative selection process. Maximum and minimum bounds on allowed doses to points in four volumes (prostate, urethra, rectum, and background) constrain the solutions for the strengths of the linear light sources. Uniform optical properties are assumed. To study how different opacities of the prostate would affect optimization, optical kernels of different light penetration were used. Another goal is to see whether the urethra and rectum can be spared, with minimal effect on PTV treatment delivery, by manipulating light illumination times of the sources. Importance weights are chosen beforehand for organ volumes, and normalized. Compared with the standard plan, our algorithm is shown to produce a plan that better spares the urethra and rectum and is very fast. Thus the combined selection of positions, lengths, and strengths of interstitial light sources improves outcome.
Keywords: Cimmino Optimization; diffusion theory; light dosimetry; photodynamic therapy; prostate; tissue optical properties.
Figures






Similar articles
-
Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.Med Phys. 2005 Dec;32(12):3524-36. doi: 10.1118/1.2107047. Med Phys. 2005. PMID: 16475751 Free PMC article. Clinical Trial.
-
A heterogeneous algorithm for PDT dose optimization for prostate.Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640B. doi: 10.1117/12.809897. Proc SPIE Int Soc Opt Eng. 2009. PMID: 25914793 Free PMC article.
-
A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.Proc SPIE Int Soc Opt Eng. 2010 Jan;7551:75510E. doi: 10.1117/12.842968. Proc SPIE Int Soc Opt Eng. 2010. PMID: 25995533 Free PMC article.
-
Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.Phys Med Biol. 2008 Aug 7;53(15):4107-21. doi: 10.1088/0031-9155/53/15/007. Epub 2008 Jul 8. Phys Med Biol. 2008. PMID: 18612172 Free PMC article.
-
Integrated light dosimetry system for prostate photodynamic therapy.Proc SPIE Int Soc Opt Eng. 2008 Jan 19;6845:68450Q. doi: 10.1117/12.763806. Proc SPIE Int Soc Opt Eng. 2008. PMID: 26113761 Free PMC article.
Cited by
-
Automatic interstitial photodynamic therapy planning via convex optimization.Biomed Opt Express. 2018 Jan 30;9(2):898-920. doi: 10.1364/BOE.9.000898. eCollection 2018 Feb 1. Biomed Opt Express. 2018. PMID: 29552420 Free PMC article.
-
A review of in-vivo optical properties of human tissues and its impact on PDT.J Biophotonics. 2011 Nov;4(11-12):773-87. doi: 10.1002/jbio.201100062. J Biophotonics. 2011. PMID: 22167862 Free PMC article. Review.
References
-
- Hsi RA, Rosenthal DI, Glatstein E. Photodynamic therapy in the treatment of cancer: current state of the art. Drugs. 1999;57:725–734. - PubMed
-
- D’Amico AV. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. J Clin Oncol. 1996;14:304–315. - PubMed
-
- Lee LK, Whitehurst C, Chen Q, Pantelides ML, Hetzel FW, Moore JV. Interstitial photodynamic therapy in the canine prostate. Br J Urol. 1997;80:898–902. - PubMed
-
- Chang SC, Buonaccorsi G, MacRobert A, Bown SG. Interstitial photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin. Int J Cancer. 1996;67:555–562. - PubMed
-
- Chang SC, Buonaccorsi G, MacRobert A, Bown SG. Interstitial photodynamic therapy of the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX. Prostate. 1997;32:89–98. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources